-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Evome Medical Technologies Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q4 2023.
- Evome Medical Technologies Inc. Depreciation for the quarter ending December 31, 2023 was CA$280K, a 89.8% increase year-over-year.
- Evome Medical Technologies Inc. Depreciation for the twelve months ending December 31, 2023 was CA$1M, a 117% increase year-over-year.
- Evome Medical Technologies Inc. annual Depreciation for 2023 was CA$1M.
- Evome Medical Technologies Inc. annual Depreciation for 2021 was CA$201K.
Depreciation, Trailing 12 Months (CAD)
Depreciation, Quarterly (CAD)
Depreciation, YoY Quarterly Growth (%)